These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15596916)

  • 1. Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.
    McCollum AD; Kulke MH; Ryan DP; Clark JW; Shulman LN; Mayer RJ; Bartel S; Fuchs CS
    Am J Clin Oncol; 2004 Oct; 27(5):485-8. PubMed ID: 15596916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma.
    Cheng PN; Saltz LB
    Cancer; 1999 Sep; 86(6):944-8. PubMed ID: 10491519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?
    Delaunoit T; Ducreux M; Boige V; Dromain C; Sabourin JC; Duvillard P; Schlumberger M; de Baere T; Rougier P; Ruffie P; Elias D; Lasser P; Baudin E
    Eur J Cancer; 2004 Mar; 40(4):515-20. PubMed ID: 14962717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorouracil, Doxorubicin with Streptozocin and Subsequent Therapies in Pancreatic Neuroendocrine Tumors.
    Rogers JE; Lam M; Halperin DM; Dagohoy CG; Yao JC; Dasari A
    Neuroendocrinology; 2022; 112(1):34-42. PubMed ID: 33434908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective treatment of locally advanced endocrine tumors of the pancreas with chemoradiotherapy.
    Strosberg J; Hoffe S; Gardner N; Choi J; Kvols L
    Neuroendocrinology; 2007; 85(4):216-20. PubMed ID: 17541257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.
    Vilar E; Tabernero J; Casado E; Macarulla T; Ramos FJ; Martinelli E; Saura C
    Am J Clin Oncol; 2005 Aug; 28(4):424. PubMed ID: 16062087
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma.
    de Vries H; Mulder NH; de Vries EG
    Cancer; 2000 May; 88(9):2194-5. PubMed ID: 10813734
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
    Kouvaraki MA; Ajani JA; Hoff P; Wolff R; Evans DB; Lozano R; Yao JC
    J Clin Oncol; 2004 Dec; 22(23):4762-71. PubMed ID: 15570077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
    N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma.
    Rivera E; Ajani JA
    Am J Clin Oncol; 1998 Feb; 21(1):36-8. PubMed ID: 9499254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors.
    Prakash L; Bhosale P; Cloyd J; Kim M; Parker N; Yao J; Dasari A; Halperin D; Aloia T; Lee JE; Vauthey JN; Fleming JB; Katz MH
    J Gastrointest Surg; 2017 Jan; 21(1):155-163. PubMed ID: 27634306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours.
    Dilz LM; Denecke T; Steffen IG; Prasad V; von Weikersthal LF; Pape UF; Wiedenmann B; Pavel M
    Eur J Cancer; 2015 Jul; 51(10):1253-62. PubMed ID: 25935542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumors.
    Fjallskog ML; Janson ET; Falkmer UG; Vatn MH; Oberg KE; Eriksson BK
    Neuroendocrinology; 2008; 88(1):53-8. PubMed ID: 18285678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group study.
    Bukowski RM; Fleming TR; Macdonald JS; Oishi N; Taylor SA; Baker LH
    Cancer; 1993 Jan; 71(2):322-5. PubMed ID: 8422624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma.
    Witte RS; Ryan LM; Schutt AJ; Carbone PP; Engstrom PF
    Invest New Drugs; 1998-1999; 16(4):315-8. PubMed ID: 10426663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial.
    Ducreux M; Dahan L; Smith D; O'Toole D; Lepère C; Dromain C; Vilgrain V; Baudin E; Lombard-Bohas C; Scoazec JY; Seitz JF; Bitoun L; Koné S; Mitry E
    Eur J Cancer; 2014 Dec; 50(18):3098-106. PubMed ID: 25454412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.
    Sun W; Lipsitz S; Catalano P; Mailliard JA; Haller DG;
    J Clin Oncol; 2005 Aug; 23(22):4897-904. PubMed ID: 16051944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors.
    Eriksson B; Skogseid B; Lundqvist G; Wide L; Wilander E; Oberg K
    Cancer; 1990 May; 65(9):1883-90. PubMed ID: 1695540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy for advanced pancreatic carcinoma].
    Yokoyama T; Shimada Y
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2338-43. PubMed ID: 1463339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of pancreatic cancer].
    Yoshimori M; Tajiri H; Nakamura K; Ozaki H
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):227-34. PubMed ID: 3155930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.